Page last updated: 2024-09-04

pralnacasan and Disease Models, Animal

pralnacasan has been researched along with Disease Models, Animal in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gerwin, N; Rudolphi, K; van den Berg, W; van der Kraan, P; Verzijl, N	1
Allan, S; Balosso, S; Bernardino, L; Ku, G; Lucas, SM; Malva, J; Noé, F; Randle, JC; Ravizza, T; Vezzani, A	1
Cornelis, S; Festjens, N; Kersse, K; Lamkanfi, M; Vandenabeele, P	1

Reviews

1 review(s) available for pralnacasan and Disease Models, Animal

Article	Year
Inflammatory caspases: targets for novel therapies. Current pharmaceutical design, 2007, Volume: 13, Issue:4 Topics: Animals; Anti-Inflammatory Agents; Autoimmune Diseases; Azepines; Brain Diseases; Caspase Inhibitors; Caspases; Disease Models, Animal; Drug Design; Enzyme Activation; Humans; Inflammation; Isoquinolines; Models, Molecular; Molecular Structure; Neurodegenerative Diseases; Protease Inhibitors; Protein Conformation; Pyridazines; Structure-Activity Relationship; Treatment Outcome	2007

Article

Year

Inflammatory caspases: targets for novel therapies.

Current pharmaceutical design, 2007, Volume: 13, Issue:4

Topics: Animals; Anti-Inflammatory Agents; Autoimmune Diseases; Azepines; Brain Diseases; Caspase Inhibitors; Caspases; Disease Models, Animal; Drug Design; Enzyme Activation; Humans; Inflammation; Isoquinolines; Models, Molecular; Molecular Structure; Neurodegenerative Diseases; Protease Inhibitors; Protein Conformation; Pyridazines; Structure-Activity Relationship; Treatment Outcome

2007

Other Studies

2 other study(ies) available for pralnacasan and Disease Models, Animal

Article	Year
Pralnacasan, an inhibitor of interleukin-1beta converting enzyme, reduces joint damage in two murine models of osteoarthritis. Osteoarthritis and cartilage, 2003, Volume: 11, Issue:10 Topics: Amino Acids; Animals; Anti-Inflammatory Agents; Azepines; Body Weight; Caspase Inhibitors; Collagen; Disease Models, Animal; Eating; Female; Hindlimb; Isoquinolines; Joints; Male; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Osteoarthritis, Knee; Pyridazines	2003
Inactivation of caspase-1 in rodent brain: a novel anticonvulsive strategy. Epilepsia, 2006, Volume: 47, Issue:7 Topics: Animals; Anticonvulsants; Azepines; Brain; Caspase 1; Caspase Inhibitors; Disease Models, Animal; Hippocampus; Interleukin-1; Isoquinolines; Kainic Acid; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Prodrugs; Protease Inhibitors; Pyridazines; Rats; Seizures; Tissue Culture Techniques	2006

Article

Year

Pralnacasan, an inhibitor of interleukin-1beta converting enzyme, reduces joint damage in two murine models of osteoarthritis.

Osteoarthritis and cartilage, 2003, Volume: 11, Issue:10

Topics: Amino Acids; Animals; Anti-Inflammatory Agents; Azepines; Body Weight; Caspase Inhibitors; Collagen; Disease Models, Animal; Eating; Female; Hindlimb; Isoquinolines; Joints; Male; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Osteoarthritis, Knee; Pyridazines

2003

Inactivation of caspase-1 in rodent brain: a novel anticonvulsive strategy.

Epilepsia, 2006, Volume: 47, Issue:7

Topics: Animals; Anticonvulsants; Azepines; Brain; Caspase 1; Caspase Inhibitors; Disease Models, Animal; Hippocampus; Interleukin-1; Isoquinolines; Kainic Acid; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Prodrugs; Protease Inhibitors; Pyridazines; Rats; Seizures; Tissue Culture Techniques

2006